BioNexus Gene Lab
BGLC
#10252
Rank
C$6.43 M
Marketcap
$0.36
Share price
-16.41%
Change (1 day)
-58.04%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2023 (TTM): -$0.06106

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -$0.06501. In 2022 the company made an earnings per share (EPS) of -$0.03426 a decrease over its 2021 EPS that were of $0.05189.

EPS history for BioNexus Gene Lab from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.0610678.23%
2022-$0.03426-166.02%
2021$0.05189-74.82%
2020$0.21-600.17%
2019-$0.04120

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.12 4,699.33%๐Ÿ‡บ๐Ÿ‡ธ USA